Found 31 matching trials
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial
CD7 CAR-T Combined With Autologous Hematopoietic Stem Cell Transplantation PHASE1 This is a single-arm, open-label, phase I/II clinical trial initiated by in...
Show More Location
The First Affiliated Hospital of Zhengzhou University, Department of Oncology
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma PHASE1 This is a single-arm, dose-escalation exploratory study evaluating the safe...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma N/A This is a single center, prospective cohort study to to evaluate the effica...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
CAR-T Following ASCT for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (R/R B-NHL) With High-Risk Prognostic Factors PHASE2 Clinical trial for the safety and efficacy of CD19 CAR-T following autologo...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). PHASE3 The purpose of this study is to measure the efficacy of AZD0120 compared wi...
Show More Learn More & Join Trial
Clinical Study of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma PHASE2 To evaluate the CR rate of B-NHL subjects who achieved PR at intermediate a...
Show More Location
The Affiliated Hospital of Xuzhou Medical University
Learn More & Join Trial
CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma PHASE1 The primary objective of this study is to explore the safety and efficacy o...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy PHASE3 The purpose of this study is to compare the efficacy of Bortezomib, Lenalid...
Show More Status
Active Not Recruiting
Learn More & Join Trial